tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Neurizon Therapeutics to Present Key ALS Research at 2025 NEALS Meeting
Company AnnouncementsNeurizon Therapeutics to Present Key ALS Research at 2025 NEALS Meeting
17h ago
Neurizon Therapeutics Announces Proposed Securities Issue
PremiumCompany Announcements
Neurizon Therapeutics Announces Proposed Securities Issue
3d ago
Neurizon Therapeutics Expands U.S. Market Presence with OTCQB Listing
PremiumCompany Announcements
Neurizon Therapeutics Expands U.S. Market Presence with OTCQB Listing
3d ago
FDA Clears Path for Neurizon’s ALS Drug NUZ-001 in Pivotal Trial
PremiumCompany Announcements
FDA Clears Path for Neurizon’s ALS Drug NUZ-001 in Pivotal Trial
5d ago
Neurizon Therapeutics Issues Unquoted Equity Securities for Employee Incentives
PremiumCompany Announcements
Neurizon Therapeutics Issues Unquoted Equity Securities for Employee Incentives
9d ago
Neurizon Therapeutics Expands Funding with Share Issuance
PremiumCompany AnnouncementsNeurizon Therapeutics Expands Funding with Share Issuance
17d ago
Neurizon Therapeutics to Quote New Securities on ASX
Premium
Company Announcements
Neurizon Therapeutics to Quote New Securities on ASX
18d ago
Neurizon Secures R&D Tax Incentive for NUZ-001 Development
Premium
Company Announcements
Neurizon Secures R&D Tax Incentive for NUZ-001 Development
23d ago
Neurizon Therapeutics Announces Proposed Securities Issue
PremiumCompany Announcements
Neurizon Therapeutics Announces Proposed Securities Issue
23d ago
Neurizon Therapeutics Secures $5 Million to Advance ALS Treatment Initiatives
PremiumCompany Announcements
Neurizon Therapeutics Secures $5 Million to Advance ALS Treatment Initiatives
23d ago
Neurizon Therapeutics Initiates Trading Halt Ahead of Capital Raising Announcement
PremiumCompany Announcements
Neurizon Therapeutics Initiates Trading Halt Ahead of Capital Raising Announcement
25d ago
Neurizon Therapeutics Reschedules 2025 AGM to Enhance Shareholder Engagement
PremiumCompany Announcements
Neurizon Therapeutics Reschedules 2025 AGM to Enhance Shareholder Engagement
1M ago
Neurizon Therapeutics to Present Q4 Updates and Strategic Initiatives
PremiumCompany AnnouncementsNeurizon Therapeutics to Present Q4 Updates and Strategic Initiatives
2M ago
Neurizon Therapeutics Releases Corporate Governance Statement
Premium
Company Announcements
Neurizon Therapeutics Releases Corporate Governance Statement
2M ago
Neurizon Therapeutics Reports Increased Financial Losses for 2025
Premium
Company Announcements
Neurizon Therapeutics Reports Increased Financial Losses for 2025
2M ago
Neurizon Therapeutics to Host Shareholder Webinar on ALS Treatment Developments
PremiumCompany Announcements
Neurizon Therapeutics to Host Shareholder Webinar on ALS Treatment Developments
2M ago
Neurizon Therapeutics Reports Positive Long-Term Results for ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics Reports Positive Long-Term Results for ALS Treatment
2M ago
Neurizon Faces FDA Review Delay for ALS Therapy NUZ-001
PremiumCompany Announcements
Neurizon Faces FDA Review Delay for ALS Therapy NUZ-001
2M ago
Neurizon Therapeutics Advances NUZ-001 Manufacturing for ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics Advances NUZ-001 Manufacturing for ALS Treatment
2M ago
Neurizon Therapeutics Sets Date for AGM and Director Nominations
PremiumCompany AnnouncementsNeurizon Therapeutics Sets Date for AGM and Director Nominations
2M ago
Neurizon Therapeutics Advances NUZ-001 Development and Secures Key Partnerships
Premium
Company Announcements
Neurizon Therapeutics Advances NUZ-001 Development and Secures Key Partnerships
2M ago
Neurizon Secures $1.5M Loan Against Future R&D Tax Rebate
Premium
Company Announcements
Neurizon Secures $1.5M Loan Against Future R&D Tax Rebate
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >